Akoya biosciences announces peer-reviewed publication using ultrahigh-plex spatial phenotyping of head and neck cancer to identify distinct immune and metabolic signatures

Marlborough, mass., oct. 17, 2023 (globe newswire) -- akoya biosciences, inc. (nasdaq: akya) (“akoya”), the spatial biology company®, today announced that researchers from akoya biosciences and the university of queensland's frazer institute have comprehensively mapped the spatial proteome of head and neck squamous cell carcinoma (hnscc) using ultrahigh-plex spatial phenotyping. spatial phenotyping consists of whole-slide imaging of tissue sections at single-cell resolution to visualize and quantitate biomarker expression and reveal how cells interact and organize across the entire tissue landscape.
AKYA Ratings Summary
AKYA Quant Ranking